IL-17 has an inverse correlation with cardiac function and tumor frequency in some SLE cohorts, suggesting a protective effect possibly by neutrophil recruitment, inducing DC maturation, activation of macrophages, and NK cell and T-cell-induced cytolysis [25]. The gene discussed is IL17A; the disease is systemic lupus erythematosus.